Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Clinical Trials
October 2, 2024
Research
Mayo Clinic secures ARPA-H award to build a living pharmacy within the body for inflammatory disease
October 2, 2024
Research
September 30, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community